RAC 0.65% $1.54 race oncology ltd

RAC - Charts & Price Action, page-19314

  1. 19,365 Posts.
    lightbulb Created with Sketch. 6488
    None of this helps - taking what seems to be a ludicrous number and making is bigger (no matter the data) doesn’t make it more believable.

    What I need is a plausible model where bisantrene has estimated peak sales around $100 million a year. Market belief in such a model would likely increase our SP by 10x. Anyone have any good ideas on how to come up with a model like this?
    Last edited by Davisite: 12/02/24
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.